Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiploma Regulatory News (DPLM)

Share Price Information for Diploma (DPLM)

Share Price is delayed by 15 minutes
Get Live Data
7,200.00    65.00 (0.91%)
Bid:
7,160.00
Ask:
7,165.00
Spread: 5.00 (0.07%)
Market Cap: £9.65b
DPLM Live PriceLast checked at - London Stock Exchange

Intraday Diploma Share Chart

Director/PDMR Shareholding

22 Dec 2025 07:00

RNS Number : 3505M
Diploma PLC
22 December 2025
 

10-11 CHARTERHOUSE SQUARE, LONDON EC1M 6EETELEPHONE: +44 (0)20 7549 5700

 

22 December 2025

 

Director/PDMR Shareholding and Long Term Incentive Award

 

Diploma PLC (the "Company") announces that on 19 December 2025, Wilson Ng, Chief Financial Officer, acquired a beneficial interest in 410 Ordinary Shares in the Company at £53.69 per share. Following this transaction, Wilson's total shareholding is 5,397 Ordinary Shares.

The shares were purchased using an amount equal to 50% of Wilson's annual bonus, net of tax, awarded for FY2025. These shares will be held under restriction in accordance with the Company's Shareholding Policy.The Company further announces that the Remuneration Committee has approved the grant of a long-term incentive award (the "Award") to Wilson on 19 December 2025 under the Diploma PLC 2020 Performance Share Plan (as amended) ("PSP"). A total of 12,289 Ordinary Shares were awarded at a share price of £53.40.

The Award is subject to the achievement of performance conditions measured over a three-year period ending 30 September 2028.The number of shares stated above represents the maximum that may vest in connection with this Award.

A summary of the PSP, including the performance conditions applicable to this Award, is provided in the Company's Annual Report and Accounts 2025.

The Notification of Dealing Form for both transactions can be found below. This announcement is made in accordance with the UK Market Abuse Regulation.

 

1

Details of the Director/PDMR/PCA

a)

Name

Wilson Ng

2

Reason for the notification

a)

Position/Status

Chief Financial Officer

b)

Initial notification/Amendment

 

Initial notification

3

Details of the issuer

a)

Name

Diploma PLC

b)

LEI

2138008OGI7VYG8FGR19

4

Details of the transactions:

a)

Description of the financial instrument, type of instrument

Identification code

 

Ordinary shares of 5p each in the Company

 

 

GB0001826634

b)

Nature of the transaction

1) Purchase of shares

2) Grant of PSP shares

c)

Price(s) and volume(s)

 

 

Price

Volume

1

Purchase at £53.69

410

2

Grant at £53.40

12,289

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

Price

Volume

1

Purchase at £53.69

410

2

Grant at £53.40

12,289

e)

Date of the transaction

19 December 2025

f)

Place of the transaction

1. London Stock Exchange

2. Outside a trading venue

 

For further information please contact:

Diploma PLC

Tel: +44 (0)20 7549 5700

Anna Lawrence, Group General Counsel & Company Secretary

 

LEI: 2138008OGI7VYG8FGR19

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFZMMZKLNGKZM
Date   Source Headline
17th Jan 20184:30 pmRNSResult of AGM
17th Jan 20187:00 amRNSTrading Statement
28th Dec 20174:13 pmRNSDirector/PDMR Shareholding
12th Dec 20173:18 pmRNSHolding(s) in Company
8th Dec 20173:00 pmRNSAnnual Financial Report & Notice of AGM
27th Nov 20174:00 pmRNSDirector/PDMR Shareholding
20th Nov 20177:00 amRNSFinal Results
25th Oct 201710:00 amRNSHolding(s) in Company
25th Oct 20179:50 amRNSHolding(s) in Company
29th Sep 20174:00 pmRNSDirector Declaration
27th Sep 20177:00 amRNSDirectorate Change
26th Sep 201712:41 pmRNSHolding(s) in Company
5th Sep 20177:00 amRNSResult of Statutory Audit Tender
30th Aug 20177:00 amRNSTrading Update
17th Aug 20173:29 pmRNSHolding(s) in Company
16th Jun 20179:00 amRNSHolding(s) in Company
14th Jun 20174:05 pmRNSDirector/PDMR Shareholding
15th May 20177:00 amRNSHalf-year Report
20th Apr 20177:00 amRNSAcquisition
18th Apr 20179:44 amRNSHolding(s) in Company
30th Mar 20177:00 amRNSTrading Update
23rd Mar 20173:05 pmRNSDirector/PDMR Shareholding
13th Mar 20172:08 pmRNSHolding(s) in Company
16th Feb 20175:10 pmRNSHolding(s) in Company
14th Feb 201711:57 amRNSHolding(s) in Company
1st Feb 20177:00 amRNSCapital Markets Day
18th Jan 20174:34 pmRNSResult of AGM
18th Jan 20177:00 amRNSTrading Statement
9th Jan 201711:30 amRNSHolding(s) in Company
5th Jan 201711:26 amRNSHolding(s) in Company
22nd Dec 20164:00 pmRNSDirector/PDMR Shareholding
22nd Dec 20163:35 pmRNSDirector Declaration
8th Dec 20163:00 pmRNSAnnual Financial Report & Notice of AGM
30th Nov 20164:00 pmRNSDirector/PDMR Shareholding
21st Nov 20167:00 amRNSFinal Results
19th Oct 20162:57 pmRNSHolding(s) in Company
31st Aug 20167:00 amRNSTrading Statement
15th Aug 20164:00 pmRNSHolding(s) in Company
13th Jun 20164:00 pmRNSNotice of Adoption of FRS 101
16th May 20167:00 amRNSHalf Year Announcement
8th Apr 201611:01 amRNSHolding(s) in Company
24th Mar 20167:00 amRNSTrading Update
9th Mar 20167:00 amRNSAcquisition
17th Feb 201610:08 amRNSHolding(s) in Company
21st Jan 20161:46 pmRNSDirector/PDMR Shareholding
21st Jan 20167:00 amRNSDirectorate Change
20th Jan 20164:58 pmRNSResult of AGM
20th Jan 20167:00 amRNSFirst Quarter Trading Update
17th Dec 201510:00 amRNSDirector/PDMR Shareholding
11th Dec 201511:38 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.